Prospective randomized study comparing sentinel lymph node evaluation with standard pathologic evaluation for the staging of colon carcinoma: Results from the United States military cancer institute clinical trials group study GI-01

Annals of Surgery

Volumn 245, Issue 6, 2007, Pages 846-857

  Stojadinovic, Alexander ^a,g   Nissan, Aviram ^b   Protic, Mladjan ^c   Adair, Carol F ^a   Prus, Diana ^b   Usaj, Slavica ^d   Howard, Robin S ^a   Radovanovic, Dragan ^e   Breberina, Milan ^d   Shriver, Craig D ^a   Grinbaum, Ronit ^b   Nelson, Jeffery M ^a   Brown, Tommy A ^f   Freund, Herbert R ^b   Potter, John F ^g   Peretz, Tamar ^b   Peoples, George E ^h  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^c Clinical Center Novi Sad   (Yugoslavia)

^d Institute of Oncology of Vojvodina

^e Clin Ctr Dr Dragisa Misovic D   (Yugoslavia)

^f MADIGAN ARMY MEDICAL CENTER   (United States)

^g United States Military Cancer Institute   (United States)

^h BROOKE ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN; EOSIN; HEMATOXYLIN; ISOSULFAN BLUE;

ARTICLE; CANCER PATIENT; CANCER STAGING; CELL AGGREGATION; CLINICAL TRIAL; COLON BIOPSY; COLON CARCINOMA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOPATHOLOGY; DIAGNOSTIC ACCURACY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MICROMETASTASIS; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SENTINEL LYMPH NODE BIOPSY; TISSUE SECTION;

AGED; CHI-SQUARE DISTRIBUTION; COLONIC NEOPLASMS; COLORING AGENTS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; KERATINS; LOGISTIC MODELS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MILITARY PERSONNEL; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES; ROSANILINE DYES; SENTINEL LYMPH NODE BIOPSY; TREATMENT OUTCOME; UNITED STATES;

EID: 34249307517     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.sla.0000256390.13550.26     Document Type: Article

References (38)

1. Le Voyer TE, Sigurdson ER, Hanlon AL, et al. Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089. J Clin Oncol. 2003;21:2912-2919.
2. Cohen Am, Kelsen D, Saltz L, et al. Adjuvant therapy for colorectal cancer. Curr Probl Cancer. 1998;22:5-65.
3. Compton CC. Updated protocol for the examination of specimens from patients with carcinomas of the colon and rectum, excluding carcinoid tumors, lymphomas, sarcomas, and tumors of the vermiform appendix: a basis for checklists. Cancer Committee. Arch Pathol Lab Med. 2000; 124:1016-1025.
4. Herrera-Ornelas L, Justiniano J, Castillo N, et al. Metastases in small lymph nodes from colon cancer. Arch Surg. 1987;122:1253-1256.
5. Rodriguez-Bigas MA, Maamoun S, Weber TK, et al. Clinical signficance of colorectal cancer: metastases in lymph nodes <5 mm in size. Ann Surg Oncol. 1996;3:124-130.
6. Bertagnolli M, Miedema B, Redston M, et al. Sentinel node staging of respectable colon cancer: results of a multicenter study. Ann Surg. 2004;240:624-630.
7. Redston M, Compton CC, Miedema BW, et al. Analysis of micrometastatic disease in sentinel lymph nodes from resectable colon cancer: results of Cancer and Leukemia Group B Trial 80001. J Clin Oncol. 2006;24:878-883.
8. Stojadinovic A, Allen PJ, Protic M, et al. Colon sentinel lymph node mapping: practical surgical applications. J Am Coll Surg. 2005;201:297-313.
9. Moher D, Schulz KF, Altman DG; CONSORT. The CONSORT statement: revised recommendations for improving the quality of reports of parallel group randomized trials. BMC Med Res Methodol. 2001;1:2.
10. Bilchik AJ, Nora D, Tollenaar RAEM, et al. Ultrastaging of early colon cancer using lymphatic mapping and molecular analysis. Eur J Cancer. 2002;38:977-985.
11. Bilchik AJ, Nora DT, Sobin LH, et al. Effect of lymphatic mapping on the new tumor-node-metastasis classification for colorectal cancer. J Clin Oncol. 2003;21:668-672.
12. Wong JH, Johnson DS, Namiki T, et al. Validation of ex vivo lymphatic mapping in hematoxylin-eosin node-negative carcinoma of the colon and rectum. Ann Surg Oncol. 2004;11:772-777.
13. Saha S, Dan AG, Beutler T, et al. Sentinel lymph node mapping technique in colon cancer. Semin Oncol. 2004;31:374-381.
14. Saha S, Monson KM, Bilchik A, et al. Comparative analysis of nodal upstaging between colon and rectal cancers by sentinel lymph node mapping: a prospective trial. Dis Colon Rectum. 2004;47:1767-1772.
15. Saha S, Seghal R, Patel M, et al. A multicenter trial of sentinel lymph node mapping in colorectal cancer: prognostic implications for nodal staging and recurrence. Am J Surg. 2006;191:305-310.
16. Bilchik A, DiNome M, Saha S, et al. Prospective multicenter trial of staging adequacy in colon cancer: preliminary results. Arch Surg. 2006; 141:527-533.
17. Viehl CT, Hamel CT, Marti WR, et al. Identification of sentinel lymph nodes in colon cancer depends on the amount of dye injected relative to tumor size. World J Surgery. 2003;27:1285-1290.
18. Patten LC, Berger DH, Rodriguez-Bigas M, et al. A prospective evaluation of radiocolloid and immunohistochemical staining in colon carcinoma lymphatic mapping. Cancer. 2004;100:2104-2109.
19. Paramo JC, Summerall J, Poppiti R, et al. Validation of sentinel node mapping in patients with colon cancer. Ann Surg Oncol. 2002;9:550-554.
20. Bilchik AJ, Saha S, Wiese D, et al. Molecular staging of early colon cancer on the basis of sentinel node analysis: a multicenter phase II trial. J Clin Oncol. 2001;19:1128-1136.
21. Feig BW, Curley S, Lucci A, et al. A caution regarding lymphatic mapping in patients with colon cancer. Am J Surg. 2001;182:707-712.
22. Wood TF, Saha S, Morton DL, et al. Validation of lymphatic mapping in colorectal cancer: in vivo, ex vivo, and laparoscopic techniques. Ann Surg Oncol. 2001;8:150-157.
23. Saha S, Wiese D, Badin J, et al. Technical details of sentinel lymph node mapping in colorectal cancer and its impact on staging. Ann Surg Oncol. 2000;7:120-124.
24. Wiese DA, Saha S, Badin J, et al. Pathologic evaluation of sentinel lymph nodes in colorectal carcinoma. Arch Pathol Lab Med. 2000;124: 1759-1763.
25. Greenson JK, Isenhart CE, Rice R, et al. Identification of occult micrometastases in pericolic lymph nodes of Duke's B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49. Correlation with long-term survival. Cancer. 1994;73:563-569.
26. Hayashi N, Ito I, Yanagisawa A, et al. Genetic diagnosis of lymph-node metastasis in colorectal cancer. Lancet. 1995;345:1257-1259.
27. Broll R, Schauer V, Schimmelpenning H, et al. Prognostic relevance of occult tumor cells in lymph nodes of colorectal carcinomas: an immunohistochemical study. Dis Colon Rectum. 1997;40:1465-1471.
28. Liefers GJ, Cleton-Jansen AM, van de Velde CJ, et al. Micrometastases and survival in stage II colorectal cancer. N Engl J Med. 1998;339:223-228.
29. Rosenberg R, Hoos A, Mueller J, et al. Prognostic significance of cytokeratin-20 reverse transcriptase polymerase chain reaction in lymph nodes of node-negative colorectal cancer patients. J Clin Oncol. 2002; 20:1049-1055.
30. Palma RT, Waisberg J, Bromberg SH, et al. Micrometastasis in regional lymph nodes of extirpated colorectal carcinoma: immunohistochemical study using anti-cytokeratin antibodies AE1/AE3. Colorectal Dis. 2003; 5:164-168.
31. Cutait R, Alves VA, Lopes LC, et al. Restaging of colorectal cancer based on the identification of lymph node micrometastases through immunoperoxidase staining of CEA and cytokeratins. Dis Colon Rectum. 1991;34:917-920.
32. Jeffers MD, O'Dowd GM, Mulcahy H, et al. The prognostic significance of immunohistochemically detected lymph node micrometastases in colorectal carcinoma. J Pathol. 1994;172:183-187.
33. Adell G, Boeryd B, Franlund B, et al. Occurrence and prognostic importance of micrometastases in regional lymph nodes in Dukes' B colorectal carcinoma: an immunohistochemical study. Eur J Surg. 1996; 162:637-642.
34. Oberg A, Stenling R, Tavelin B, Lindmark G. Are lymph node micrometastases of any clinical significance in Dukes Stages A and B colorectal cancer? Dis Colon Rectum. 1998;41:1244-1249.
35. Nakanishi Y, Ochiai A, Yamauchi Y, et al. Clinical implications of lymph node micrometastases in patients with colorectal cancers. A case control study. Oncology. 1999;57:276-280.
36. Choi HJ, Choi YY, Hong SH. Incidence and prognostic implications of isolated tumor cells in lymph nodes from patients with Dukes B colorectal carcinoma. Dis Colon Rectum. 2002;45:750-755.
37. Fisher ER, Colangelo L, Wieand S, et al. Lack of influence of cytokeratin-positive mini micrometastases in "Negative Node" patients with colorectal cancer: findings from the national surgical adjuvant breast and bowel projects protocols R-01 and C-01. Dis Colon Rectum. 2003;46: 1021-1025.
38. Wong JH, Steinemann S, Tom P, et al. Volume of lymphatic metastases does not independently influence prognosis in colorectal cancer. J Clin Oncol. 2002;20:1506-1511.